1AD
Click for more information
4.00% 2.6¢ adalta limited

Ann: Positive AD-214 Phase I extension study results, page-210

  1. Beno77
    5,299 Posts.
    lightbulb Created with Sketch. 646
    clock Created with Sketch.
    27/03/24
    19:21
    Post #: 73090300
    mate look at why they asked to do the extension study, it was all about making sure it’s human ready at the effective dose given to mice.


    1AD Price at posting: 2.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
(20min delay)
Last
2.6¢ 		Change
0.001(4.00%) 		Mkt cap ! $15.48M
Open High Low Value Volume
2.5¢ 2.6¢ 2.5¢ $8.104K 311.8K

Buyers (Bids)

No. Vol. Price($)
3 1654221 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.6¢ 75000 1
View Market Depth
Last trade - 11.45am 26/06/2024 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.